TABLE 5.

Estimates of clinical change (95% CIs) on outcome measures following treatment (n = 824)

	PHQ‐9	PHQ‐2	GAD‐7	GAD‐2
Group‐level	35% (31%–39%)	34% (29%–39%)	33% (28%–38%)	32% (26%–38%)
Proportion ≥30%	0.59 (0.55–0.62)	0.58 (0.55–0.61)	0.58 (0.54–0.61)	0.59 (0.55–0.62)
Proportion ≥50%	0.41 (0.37–0.44)	0.48 (0.44–0.51)	0.42 (0.38–0.46)	0.50 (0.46–0.54)